Acer Medical Inc. (TPEX:6857)
Taiwan · Delayed Price · Currency is TWD 90.50
-0.50 (-0.55%)
Oct 8, 2026, 1:27 PM CST
Acer Medical Market Cap
Acer Medical has a market cap or net worth of 1.38 billion as of October 9, 2026. It is the 31,476th most valuable company in the world and the 1,878th biggest in Taiwan. Its market cap has decreased by 24.58% in one year.
Market Cap
1.38B
Enterprise Value
1.22B
Revenue
70.47M
Global Rank
Country Rank
#1,878 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since October 27, 2021, Acer Medical's market cap has increased from 720.00M to 1.38B, an increase of 91.38%. That is a compound annual growth rate of 14.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 1.38B | -8.59% |
| Dec 31, 2025 | 1.51B | -30.28% |
| Dec 30, 2024 | 2.16B | -23.66% |
| Dec 29, 2023 | 2.83B | 154.79% |
| Dec 30, 2022 | 1.11B | -1.98% |
| Dec 21, 2021 | 1.13B | 57.50% |
| Oct 27, 2021 | 720.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 495.25B |
| Lin BioScience | 145.11B |
| Caliway Biopharmaceuticals | 120.54B |
| Heron Neutron Medical | 81.84B |
| Medical Imaging | 1.50B |
| AViTA | 1.47B |
| GenMont Biotech Incorporation | 1.46B |
| Advagene Biopharma | 1.42B |